Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mori, I. Articles by Nishiyama, Y. Search for Related Content PubMed PubMed Citation Articles by Mori, I. Articles by Nishiyama, Y.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2004, p. 936-937, Vol. 42, No. 2
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.2.936-937.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

PCR Search for the Herpes Simplex Virus Type 1 Genome in Brain Sections of Patients with Familial Alzheimer's Disease

Top Letter References

 
An association between Chlamydia pneumoniae and Alzheimer's disease (AD) remains questionable (3, 5). Herpes simplex virus type 1 (HSV-1), the most ubiquitous neurotropic virus in humans, has been proposed as a risk factor for AD, although this issue is still under debate. Itzhaki et al. raised the possibility that the presence of HSV-1 in the brain is a risk factor for AD in elderly people carrying the apolipoprotein E 4 allele (4). Strandberg noticed a significant association between serologically measured viral burden and cognitive impairment in elderly people (6). On the other hand, Beffert et al. argued that HSV-1 in the brain does not confer an increased risk for AD when combined with the apolipoprotein E 4 allele and that 4 carriers are not more susceptible to HSV-1 infection than are non-4 carriers (1).

Familial AD, the least common type of AD, is characterized by the early onset of the disease (at 35 to 60 years of age) with early neuropathological alterations, including ß-amyloid deposition. Mutations on the amyloid precursor protein, presenilin-1, and presenilin-2 genes have been identified in familial AD patients. However, other possible mechanisms underlying the pathology of familial AD, including the involvement of HSV-1 in the deterioration phase of the disease, have not been addressed.

By using nested PCR, we examined formalin-fixed, paraffin-embedded, postmortem brain tissue from three individuals with familial AD, six without AD, and two with sporadic AD for the presence of HSV-1 glycoprotein D (Table 1). A mutation on the presenilin-1 gene had been identified in patient 1. HSV-1 DNA was detected in the brains of all three familial-AD individuals, preferentially in the frontal and temporal lobes, whereas it was not found in any parts of the brains of non-AD group members except patient 9, whose frontal lobe was HSV-1 positive. In situ hybridization (using a DAKO GenPoint tyramide signal amplification system and an ENZO HSV DNA probe) detected HSV DNA in the frontal and temporal cortex neurons of patients 1 and 2, with the virus-specific signal being detected predominantly in the cytoplasm in a dotlike staining pattern. Furthermore, high-sensitivity immunohistochemistry (DAKO ENVISION+) detected HSV-1 antigens in the frontal- and temporal-cortex neurons of patients 1 and 2 in a cytoplasmic staining fashion. A moderate to high level of ß-amyloid deposition was detected in the brains of all three familial- and both sporadic-AD patients, whereas it was not evident in the non-AD brains except that of patient 9, whose brain exhibited moderate ß-amyloid deposition.

View this table: [in this window] [in a new window]

TABLE 1. Detection of the HSV-1 genome in brain sections of patients with familial AD

These results (the presence of viral DNA and antigens in neuronal cytoplasm) are suggestive of limited reactivation of HSV-1, coupled with ß-amyloid deposition, in the brains of individuals with familial AD. In a latent state, virus genomes are harbored in the nucleus but not in the cytoplasm of neurons (7). Significantly, ß-amyloid fibrils have been demonstrated to stimulate infection with enveloped viruses, including HSV, in vitro (8). Additionally, glycoprotein B of HSV-1, the internal sequence of which has homology to the carboxyl-terminal region of the ß-amyloid peptide, has been shown to promote fibril formation in vitro (2). Thus, there appears to exist a close association between ß-amyloid deposition and HSV-1 reactivation in the human brain. Since repeated reactivation of HSV-1 in neurons likely promotes neurodegeneration in AD brains, preventive and therapeutic measures against HSV-1 may be applied not only to sporadic but also to familial AD.

 
We thank N. Takimoto, R. Ishihara, E. Iwata, and T. Tsuruguchi for technical assistance.

This work was supported in part by JSPS KAKENHI (15590424).

Top Letter References

 

1
1. Beffert, U., P. Bertrand, D. Champagne, S. Gauthier, and J. Poirier. 1998. HSV-1 in brain and risk of Alzheimer's disease. Lancet 351:1330-1331.
2
2. Cribbs, D. H., B. Y. Azizeh, C. W. Cotman, and F. M. LaFerla. 2000. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's Aß peptide. Biochemistry 39:5988-5994.[CrossRef][Medline]
3
3. Gieffers, J., E. Reusche, W. Solbach, and M. Maass. 2000. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. J. Clin. Microbiol. 38:881-882.[Abstract/Free Full Text]
4
4. Itzhaki, R. F., W.-R. Lin, D. Shang, G. K. Wilcock, B. Faragher, and G. A. Jamieson. 1997. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349:241-244.[CrossRef][Medline]
5
5. Ring, R. H., and J. M. Lyons. 2000. Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J. Clin. Microbiol. 38:2591-2594.[Abstract/Free Full Text]
6
6. Strandberg, T. E. 2003. Alzheimer's disease and angiogenesis. Lancet 361:1298-1299.
7
7. Wagner, E. K., and D. C. Bloom. 1997. Experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 10:419-443.[Abstract]
8
8. Wojtowicz, W. M., M. Farzan, J. L. Joyal, K. Carter, G. J. Babcock, D. I. Israel, J. Sodroski, and T. Mirzabekov. 2002. Stimulation of enveloped virus infection by ß-amyloid fibrils. J. Biol. Chem. 277:35019-35024.[Abstract/Free Full Text]

						Isamu Mori* Takashi Yokochi Naoki Koide Tsuyoshi Sugiyama Tomoaki Yoshida Department of Microbiology and Immunology Research Center for Infectious Disease Aichi Medical University School of Medicine Aichi 480-1195, Japan Yoshinobu Kimura Hironobu Naiki Rokuro Matsubara Department of Microbiology, Pathology, and  Neuropsychiatry Fukui Medical University School of Medicine Fukui 910-1193, Japan Tohru Takeuchi Yukihiro Nishiyama Department of Psychiatry and Laboratory  of Virology Institute for Disease Mechanism and Control Nagoya University Graduate School  of Medicine Nagoya 466-8550, Japan
						* Phone: 81-52-264-4811, Fax: 81-561-62-4866, E-mail: isamor{at}aichi-med-u.ac.jp

---

Journal of Clinical Microbiology, February 2004, p. 936-937, Vol. 42, No. 2
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.2.936-937.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mori, I. Articles by Nishiyama, Y. Search for Related Content PubMed PubMed Citation Articles by Mori, I. Articles by Nishiyama, Y.